Overview

NT-101 Topical Ophthalmic Solution in Patients With Wet AMD

Status:
RECRUITING
Trial end date:
2025-12-24
Target enrollment:
Participant gender:
Summary
Phase 1/2 Trial NT-101 Topical Ophthalmic Solution in Patients with Wet Age-Related Macular Degeneration (AMD)
Phase:
PHASE1
Details
Lead Sponsor:
NexThera Co., Ltd.
Collaborator:
KCRN Research, LLC